Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03152565 | Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients | ||
| NCT05809830 | Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas | ||
| NCT03985722 | Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients | ||
| NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | ||
| NCT03242382 | Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. | ||
| NCT02806648 | A Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET) | ||
| NCT04986085 | Nutrition in Gastroenteropancreatic Neuroendocrine Tumor | ||
| NCT07248644 | Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission | ||
| NCT06878664 | Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors | ||
| NCT05390671 | CAR-T Cell Therapy in Patients With Hematological Malignancies | ||
| NCT03415867 | Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease | ||
| NCT03753919 | Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial | ||
| NCT01710176 | Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy | ||
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. | ||
| NCT01484080 | Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates | ||
| NCT01567488 | Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET | ||
| NCT05271773 | Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis | ||
| NCT01684449 | Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | ||
| NCT03142516 | FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status | ||
| NCT02275286 | Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients | ||
| NCT07061080 | Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab | ||
| NCT02921555 | Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis | ||
| NCT05698745 | Immunological Characteristics of Preclinical IBD | ||
| NCT06837090 | Retrospective Analysis of the Experience With Larotrectinib in Patients With Solid Neoplasms With NTRK Fusion in Spain (SPAINTRK) | ||
| NCT01956903 | Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. | ||
| NCT04400474 | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | ||
| NCT04181970 | Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK | ||
| NCT04595266 | Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease | ||
| NCT03751176 | Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal | ||
| NCT01280201 | Pazopanib as Single Agent in Advanced NETs | ||
| NCT06235216 | Sacituzumab govitEcan in THYroid Cancers | ||
| NCT02904590 | A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease | ||
| NCT02713763 | Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib | ||
| NCT04138381 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) | ||
| NCT00083174 | Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer | ||
| NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | ||
| NCT00541840 | Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma | ||
| NCT05146440 | Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor | ||
| NCT04595994 | Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma | ||
| NCT05131386 | Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas | ||
| NCT01683123 | Study With Intravenous Busulfan And Fludarabine Myeloablative Conditioning Regimen For HLA Identical Sibling Donor HSCT | ||
| NCT05918302 | Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. | ||
| NCT03727113 | Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors | ||
| NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | ||
| NCT06031038 | Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU | ||
| NCT05660954 | Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. | ||
| NCT01455051 | Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation | ||
| NCT01692496 | Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial | ||
| NCT06844318 | Impact of IBD Activity on Frailty in Patients Over 60 Years | ||
| NCT02678780 | Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors |
